EMA: New facilities for the production of the Pfizer vaccine

The EMA Human Medicines Committee (CHMP) has approved additional production sites for the production of the Comirnaty, BioNTech / Pfizer COVID-19 vaccine.

The facility is in Frankfurt, Germany, operated by Sanofi-Aventis Deutschland GmbH. The other location is in Hamelin, also in Germany, and is operated by Siegfried Hameln GmbH.

Both plants will produce the final product while providing up to 50 million additional installments in 2021.